Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-04-30 @ 7:05 PM
Study NCT ID:
NCT02628067
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-22
First Post:
2015-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Cancer | View |
| None | Anal Carcinoma | View |
| None | Anal Cancer | View |
| None | Biliary Cancer | View |
| None | Cholangiocarcinoma | View |
| None | Bile Duct Cancer | View |
| None | Neuroendocrine Tumor | View |
| None | Carcinoid Tumor | View |
| None | Endometrial Carcinoma | View |
| None | Endometrial Cancer | View |
| None | Cervical Carcinoma | View |
| None | Cervical Cancer | View |
| None | Vulvar Carcinoma | View |
| None | Vulvar Cancer | View |
| None | Small Cell Lung Carcinoma | View |
| None | Small Cell Lung Cancer (SCLC) | View |
| None | Mesothelioma | View |
| None | Thyroid Carcinoma | View |
| None | Thyroid Cancer | View |
| None | Salivary Gland Carcinoma | View |
| None | Salivary Gland Cancer | View |
| None | Salivary Cancer | View |
| None | Parotid Gland Cancer | View |
| None | Advanced Solid Tumors | View |
| None | Colorectal Carcinoma | View |